Evidence map›Paper›PMID 1757957›Full record

ArticleJournal of medical genetics1991

Genotype prediction in the fragile X syndrome.

M C Hirst, Y Nakahori, S J Knight, C Schwartz, S N Thibodeau, A Roche, T J Flint, J M Connor, J P Fryns, K E Davies

Abstract read
In one paragraph

Article in Journal of medical genetics, 1991. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Origins of the fragile X syndrome mutation.Journal of medical genetics · 1993
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Molecular analysis of the fragile X syndrome.Journal of inherited metabolic disease · 1992
    Review
  15. Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

M C HirstInstitute of Molecular Medicine, John Radcliffe Hospital, Headington, Oxford.
Y Nakahori
S J Knight
C Schwartz
S N Thibodeau
A Roche
T J Flint
J M Connor
J P Fryns
K E Davies

Funding

NEUROCOG, EMOT, &PHYS PHENOTYPE OF FRAGILE X FEMALESR01MH045916 · NIMH · CHILDREN'S HOSPITAL OF DENVER · PI HAGERMAN, RANDI J · 1990 to 1994
–
NIMH NIH HHS MH45916
6 · The paper itself

Abstract

Fragile X positive, mentally retarded males have been shown to have an insertion or amplification of DNA sequences at, or close to, the site of expression of the fragile site. We show here the application of the detection of such changes to the diagnosis of affected males and female carriers and the identification of normal transmitting males. One fragile X negative male with the clinical features of the Martin-Bell syndrome also possesses an inserted/amplified DNA sequence. The implications of these results for screening for the fragile X syndrome are discussed.

Indexed as

Blotting, SouthernDNADNA ProbesFemaleFragile X SyndromeGene AmplificationGenetic MarkersGenotypeHumansMalePedigreeRestriction MappingDNADNA ProbesGenetic Markers

Identifiers

PMID1757957
PMCPMC1017158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.